EVA1A and breast carcinoma: Interestingly, our results support that DRP1-mediated mitophagy is involved in the anti-cancer effects of EVA1A, as evidenced by silencing DRP1 blocks the anti-proliferative and anti-migration effects of EVA1A overexpression in breast cancer.